Investor Stock List
Ranked #7,272 of 8,699 institutional investors

Birchview Capital, LP

Burlington, VT

$141M
US stock portfolio at live prices · today −$2.2M (−1.55%)
Market closed. Prices as of Nov 20, 7:11 AM ET
Value at quarter end (Q3 2026)
$173M
Change from Q2 2026
−$40.7M (−19.04%)
Positions
68 · 15 new, 13 sold out
Filed
Nov 13, 2026

Not counted in the ranking: none$12.7M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
KLAC 16.7%BMY 9.26%OVV 4.69%RARE 4.56%LRCX 4.33%
StockSharesValue, live% of portfoliovs Q2 2026
KLAC KLA Corporation166,938$23.6M16.7%Reduced −6%
BMY Bristol-Myers Squibb Company224,245$13.1M9.26%Reduced −25%
OVV Ovintiv Inc.107,500$6.6M4.69%Unchanged
RARE Ultragenyx Pharmaceutical Inc.373,671$6.4M4.56%New
LRCX Lam Research Corporation30,000$6.1M4.33%Reduced −14%
SLDB Solid Biosciences Inc.715,955$4.6M3.26%Added +7%
PTGX Protagonist Therapeutics, Inc.35,000$4.3M3.07%Unchanged
NBIX Neurocrine Biosciences, Inc.25,190$3.9M2.79%Reduced −7%
STOK Stoke Therapeutics, Inc.138,000$3.7M2.63%Reduced −23%
CORT Corcept Therapeutics Incorporated55,200$3.6M2.54%Reduced −3%
HALO Halozyme Therapeutics, Inc.33,351$3.1M2.20%Added +0%
ACAD Acadia Pharmaceuticals Inc.171,000$3.0M2.13%Unchanged
NTLA Intellia Therapeutics, Inc.281,365$2.7M1.90%Reduced −27%
BDSX Biodesix, Inc.286,804$2.4M1.69%Unchanged
ZBIO Zenas BioPharma, Inc.93,380$2.3M1.66%Reduced −0%
BIIB Biogen Inc.9,000$2.2M1.57%Unchanged
VIR Vir Biotechnology, Inc.226,992$2.0M1.43%Added +3%
EQT EQT Corporation34,619$1.7M1.21%Unchanged
ABVX ABIVAX Société Anonyme21,000$1.7M1.20%Added +24%
IRLA IRulya Therapeutics Inc.40,601$1.6M1.15%New
XENE Xenon Pharmaceuticals Inc.42,995$1.6M1.14%Added +104%
CLDX Celldex Therapeutics, Inc.57,200$1.6M1.13%Reduced −18%
CYTK Cytokinetics, Incorporated30,000$1.5M1.09%Unchanged
DFTX Definium Therapeutics, Inc.52,000$1.5M1.09%Added +160%
NKTR Nektar Therapeutics46,000$1.5M1.06%Reduced −43%
BBIO BridgeBio Pharma, Inc.18,741$1.5M1.04%Added +114%
UTHR United Therapeutics Corporation2,500$1.4M0.99%Reduced −45%
RLMD Relmada Therapeutics, Inc.408,100$1.3M0.90%Unchanged
TVTX Travere Therapeutics, Inc.25,000$1.2M0.86%Reduced −14%
VALN Valneva SE201,390$1.1M0.77%New
CMPX Compass Therapeutics, Inc.1,575,000$1.1M0.76%Reduced −6%
IMNM Immunome, Inc.55,600$924K0.65%Added +11%
FCX Freeport-McMoRan Inc.18,027$885K0.63%Unchanged
ADAG Adagene Inc.430,000$864K0.61%Added +79%
AXSM Axsome Therapeutics, Inc.6,000$814K0.58%Unchanged
QDEL QuidelOrtho Corporation89,377$797K0.56%Unchanged
HROW Harrow, Inc.24,000$771K0.55%Unchanged
CSTL Castle Biosciences, Inc.22,935$766K0.54%Added +77%
BLSM BlossomHill Therapeutics, Inc.50,000$721K0.51%New
SLN Silence Therapeutics plc30,000$594K0.42%Reduced −58%
LUNG Pulmonx Corporation200,000$548K0.39%Reduced −0%
BCYC Bicycle Therapeutics plc176,432$538K0.38%Reduced −44%
FHTX Foghorn Therapeutics Inc.282,307$503K0.36%Added +0%
CAMP Camp4 Therapeutics Corp120,000$480K0.34%Unchanged
VOR Vor Biopharma Inc.24,000$444K0.31%New
OLMA Olema Oncology, Inc.59,000$422K0.30%Reduced −70%
MLTX MoonLake Immunotherapeutics36,220$400K0.28%New
VYGR Voyager Therapeutics, Inc.224,918$362K0.26%Added +199%
TRIN Trinity Capital Inc.20,000$338K0.24%Unchanged
CRMD CorMedix Inc.65,874$335K0.24%New
DRUG Bright Minds Biosciences Inc.15,400$319K0.23%New
AEMD Aethlon Medical, Inc.62,837$304K0.22%New
PACB Pacific Biosciences of California, Inc.160,000$282K0.20%Reduced −88%
RZLT Rezolute, Inc.60,296$253K0.18%New
KBDC Kayne Anderson BDC, Inc.20,000$242K0.17%Unchanged
ALT Altimmune, Inc.160,964$227K0.16%Added +5%
ABEO Abeona Therapeutics Inc.90,700$222K0.16%New
CGEM Cullinan Therapeutics, Inc.20,000$181K0.13%Unchanged
TRDA Entrada Therapeutics, Inc.36,849$171K0.12%New
IMUX Immunic, Inc.21,917$162K0.11%New
ELUT Elutia Inc.165,094$134K<0.1%Unchanged
OCUL Ocular Therapeutix, Inc.20,450$120K<0.1%Reduced −1%
CRDL Cardiol Therapeutics Inc.100,000$88K<0.1%New
BMEA Biomea Fusion, Inc.93,500$55K<0.1%New
KYNB Kyntra Bio, Inc.22,566$41K<0.1%Unchanged
IVVD Invivyd, Inc.75,975$34K<0.1%Reduced −78%
LPCN Lipocine Inc.16,712$25K<0.1%Unchanged
DCGO DocGo Inc.39,062$7K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
VERA Vera Therapeutics, Inc.57,758$1.5M
NVO Novo Nordisk A/S24,000$933K
FDMT 4D Molecular Therapeutics, Inc.48,505$520K
SVRA Savara Inc.80,000$417K
GPCR Structure Therapeutics Inc.24,000$411K
BIOA BioAge Labs, Inc.69,000$325K
PHAT Phathom Pharmaceuticals, Inc.55,000$279K
CMPS COMPASS Pathways plc30,000$260K
CADL Candel Therapeutics, Inc.47,756$245K
GRCE Grace Therapeutics, Inc.120,000$208K
CAPR Capricor Therapeutics, Inc.14,352$108K
QNRX Quoin Pharmaceuticals, Ltd.20,000$67K
GOSS Gossamer Bio, Inc.227$3K